Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Extracellular Matrix Protein Signatures of Cortical and Cancellous Bone Allografts Following Processing for Clinical Use.

Cells·2026
Same author

Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum.

Journal of clinical medicine·2026
Same author

Stem cell modelling of osteoarthritis using an organ-on-a-chip approach.

Inflammation and regeneration·2025
Same author

Extracellular vesicles from primed Hoffa's fat pad mesenchymal stem/stromal cells in osteoarthritis therapy: effects on cells critical to osteoarthritis progression.

Stem cell research & therapy·2025
Same author

Freeze drying and Lugol staining of human menisci reveal circumferential fibre volumes to guide meniscus implant design and virtual simulation.

Scientific reports·2025
Same author

Longitudinal patterns of mental well-being over four years in a german general population sample: a growth mixture modeling approach.

BMC public health·2025

Related Experiment Video

Updated: Jun 14, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

3.7K

Exploring Osteoarthritis Dynamics: Patient-Specific Cartilage Samples in an Organ-on-a-Chip Model.

Markus Pasztorek1, Johanna Fischer1, Alexander Otahal2

  • 1Pregenerate GmbH, Vienna, Austria.

Cartilage
|September 5, 2024
PubMed
Summary

This study developed an organ-on-a-chip tool to predict patient-specific responses to osteoarthritis treatments. Findings show individualized drug effects, highlighting the need for personalized medicine to minimize joint damage.

Keywords:
3D culturechondrocytesmicrofluidic deviceorgan on a chiposteoarthritis

More Related Videos

Addressing Practical Issues in Atomic Force Microscopy-Based Micro-Indentation on Human Articular Cartilage Explants
08:06

Addressing Practical Issues in Atomic Force Microscopy-Based Micro-Indentation on Human Articular Cartilage Explants

Published on: October 28, 2022

957
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
07:32

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

12.0K

Related Experiment Videos

Last Updated: Jun 14, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

3.7K
Addressing Practical Issues in Atomic Force Microscopy-Based Micro-Indentation on Human Articular Cartilage Explants
08:06

Addressing Practical Issues in Atomic Force Microscopy-Based Micro-Indentation on Human Articular Cartilage Explants

Published on: October 28, 2022

957
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
07:32

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

12.0K

Area of Science:

  • Biomaterials Science
  • Pharmacology
  • Regenerative Medicine

Background:

  • Osteoarthritis (OA) poses challenges in predicting pharmaceutical intervention effectiveness.
  • Current treatments often lack patient-specific optimization, leading to suboptimal outcomes.
  • Articular cartilage, the primary affected tissue in OA, requires targeted therapeutic strategies.

Purpose of the Study:

  • To develop an innovative tool for objective, patient-specific prediction of pharmaceutical interventions for OA.
  • To assess individual drug responses in a 3D in vitro cartilage model.
  • To identify biomarkers associated with variable drug responses in OA patients.

Main Methods:

  • Organ-on-a-chip (OoC) technology was utilized to create a 3D in vitro cartilage model.
  • Individual responses to common OA medications were evaluated using the OoC platform.
  • Biomarker analysis was performed to investigate patient-specific drug response variability.

Main Results:

  • Osteoarthritis articular cartilage exhibits individualized responses to pharmaceutical treatments.
  • Triamcinolone demonstrated consistent anti-inflammatory effects but also associated degeneration, mirroring clinical observations.
  • Biomarker analysis confirmed the significance of individual drug responses for effective treatment planning.

Conclusions:

  • The developed OoC tool accurately mimics cartilage structure and provides insights into patient-specific OA treatment responses.
  • OoC application enables precise assessment of treatment efficacy and personalized treatment planning.
  • Objective, patient-specific biomarker analysis facilitates tailored OA management, minimizing joint damage and advancing personalized medicine.